Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 157-162

  Yang, Chi Rei ^a   Ou, Yen Chuan ^a   Kuo, Jehn Hwa ^a   Kao, Yu Lin ^a   Chen, Chen Li ^a   Yean, Sheau Yun ^a   Horng, Yu Ye ^a   Yang, Chung Shi ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chemotherapy response; Drug resistance; Glutathione; Urothelial cancer

Indexed keywords

CISPLATIN; EPIRUBICIN; GLUTATHIONE; METHOTREXATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER TISSUE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE LEVEL; UROGENITAL TRACT TUMOR;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CYTARABINE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; MITOXANTRONE; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0030694485     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00274-7     Document Type: Article

References (26)

1. S. Kuzmich, K.D. Tew, Detoxification mechanism and tumor cell resistance to anticancer drug, Med. Res. Rev. 11 (1991) 185-217.
2. J. Ogawa, M. Iwazaki, H. Inoue, S. Koide, A. Shohtsu, Immunohistochemical study of glutathione-related enzymes and proliferative antigen in lung cancer, Cancer 71 (1993) 2204.
3. A. Meister, Glutathione metabolism and its selective modification, J. Biol. Chem. 263 (1988) 17205-17208.
4. B. Coles, Effects of modifying structure on electrophilic reactions with biological nucleophiles. Drug Metab. Rev. 15 (1984-1985) 1307.
5. C. Meijer, N.H. Mulder, G.A.P. Hospers, D.R.A. Uges, E.G.E, de Vries, The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line, Br. J. Cancer 62 (1990) 72-77.
6. V.M. Richon, N. Shulte, A. Eastman, Multiple mechanism of resistance to cis-diamminedichloroplatinum (II) in murine leukemia L1210 cells, Cancer Res. 47 (1987) 2056-2061.
7. T.C. Hamilton, M.A. Winker, K.G. Louie et al., Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion, Biochem. Pharmacol. 34 (1985) 2583.
8. H. Ahn, E. Lee, K. Kim, C. Lee, Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines, J. Urol. 151 (1994) 263-267.
9. S. Velury, S.B. Howell, Measurement of plasma thiols after derivatization with monobromobimane, J. Chromatogr. 424 (1988) 141-146.
10. A.M. Svardal, M.A. Mansoor, P.M. Ueland, Determination of reduced, oxidized and protein-bound glutathione in human with precolumn derivatization with monobromobimane and liquid chromatography, Anal. Biochem. 184 (1990) 338-346.
11. M.M. Bradford, A rapid and sensitive method for quantita tion of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
12. C.N. Sternberg, A. Yogoda, H.I. Scher et al., Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin, cisplatin) for transitional cell carcinoma of the urothelium, J. Urol. 133 (1985) 403-407.
13. C.N. Sternberg, A. Yogoda, H.I. Scher et al., Long term survival in advanced urothelium cancer with MVAC: the first two years of accrual, J. Urol. 137 (1987) 157A.
14. D. Raghavan, Chemotherapy for advanced bladder cancer: A Midsummer Night's Dream or Much ado about Nothing, Br. J. Cancer 62 (1990) 337-340.
15. C. Yang, H. Wu, C. Chang, T.I. Hwang, C. Chang, Chemotherapy of advanced urothelial cancer - the implication on patient's compliance relating to response, J. Urol. 147 (1992) 447A.
16. V. Devita, The relationship between tumor mass and resistance to chemotherapy, Cancer (Philadelphia) 51 (1983) 1209-1220.
17. J.H. Goldie, A.J. Coldmen, The genetic origin of drug resistance in neoplasm, implications of systemic chemotherapy, Cancer Res. 44 (1984) 3643-3653.
18. L.A. Klein, G. Allen, W.R. Fair, V. Reuter, A. Changantic, Absence of structure alternations of the multidrug resistance genes in transitional cell carcinoma, Urol. Res. 18 (1990) 281-286.
19. F. Suzukake, B.J. Petero, D.T. Uistica, Reduction in glutathione content of L-PAM resistant L1210 cells confer drug sensitivity, Biochem. Pharmacol. 31 (1982) 121-124.
20. T.C. Hamilton, R.C. Young, R.F. Ozols, Experimental model systems of ovarian cancer, Semin. Oncol. 11 (1984) 285-298.
21. R.F. Ozol, K.G. Louie, J. Plowman, B.C. Behrens, R.L. Fine, D. Dykes, T.C. Hamilton, Enhanced alkylating agent cytotoxicity in human ovarian cancer in vitro and in tumor bearing nude mice by buthionine sulfoximine depletion of glutathione, Biochem. Pharmacol. 36 (1986) 147-153.
22. D.Y. Wong, Y. Hsiao, C. Poon, S. Kwan, S.-u. Chou, C. Yang, Glutathione concentration in oral cancer tissue. Cancer Lett. 81 (1994) 111-116.
23. T.C. Chang, M.J.W. Chang, S. Hsueh, Glutathione concentration and distribution in cervical cancers and adjacent normal tissues, Gynecol. Obstet. Invest. 36 (1993) 52-55.
24. J.A. Cook, H.I. Pass, S.N. Iype, N. Friedman, W. Degraff, A. Russo, J.B. Mitchell, Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue, Cancer Res. 51 (1991) 4287-4294.
25. G.M. Lai, R.F. Ozols, R.C. Young, T.C. Hamilton, Effects of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines, J. Natl. Cancer Inst. 81 (1989) 535-539.
26. A. Lafuente, M. Giralt, I. Cervello, F. Pujol, J. Mallol, Glutathione-S transferase activity in human superficial transitional cell carcinoma of bladder comparison with healthy controls, Cancer 65 (1990) 2064-2068.